SOD1 and cancer: Previous studies revealed superoxide dismutase (an antioxidant) activity facilitated anoikis resistance in ECM detached cancer cells [31,32,33], so we sought to investigate the effect of metformin treatment on two antioxidant families glutathione peroxidase 1–3 and superoxide dismutase 1–3 (Figure 3H).